Moneycontrol
HomeNewsBusinessCompaniesWith Sun Pharma-Merck striking JV, why is SPARC shining?
Trending Topics

With Sun Pharma-Merck striking JV, why is SPARC shining?

According to CNBC-TV18's research analyst Ekta Batra it's SPARC which has emerged as the winner from this deal between Sun Pharma and Merck. They are targeting a portfolio of around 12 drugs in around 100 countries but the focus is expected to be the top 10 countries which are expected to contribute around 80% of revenues.

April 15, 2011 / 08:34 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

SPARC has seen double digit gains today after Sun Pharma the parent company said that Merck & Co will contribute to its technology through a Joint Venture (JV) wherever necessary. Sun Pharma is touted as one of the fastest growing company

first published: Apr 13, 2011 02:37 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!